Literature DB >> 11879180

Substrate access channel topology in membrane-bound prostacyclin synthase.

Hui Deng1, Aimin Huang, Shui-Ping So, Yue-Zhen Lin, Ke-He Ruan.   

Abstract

Results from our molecular-modelling and site-directed-mutagenesis studies of prostaglandin I(2) synthase (PGIS) have suggested that the large PGIS cytoplasmic domain is anchored to the endoplasmic reticulum (ER) membrane by the N-terminal segment in a way that orients the substrate access channel opening to face the membrane. To test this hypothesis we have explored the accessibility of the PGIS substrate channel opening to site-specific antibodies. The working three-dimensional PGIS model constructed by protein homology modelling was used to predict surface portions near the substrate access channel opening. Two peptides corresponding to the surface immediately near the opening [residues 66-75 (P66-75) and 95-116 (P95-116)], and two other peptides corresponding to the surface about 10-20 A (1 A=0.1 nm) away from the opening [residues 366-382 (P366-382) and 472-482 (P472-482)] were used to prepare site-specific antibodies. All four antipeptide antibodies specifically recognized the synthetic segments of human PGIS and recombinant PGIS, as shown by binding assays and Western-blot analysis. The site-specific antibodies were used to probe the accessibility of the substrate access channel opening in transiently transfected COS-1 cells expressing recombinant human PGIS, and in spontaneously transformed human endothelial cell line ECV cells expressing endogenous human PGIS. Immunofluorescence staining was performed for cells selectively permeabilized with streptolysin O and for cells whose membranes were permeabilized with detergent. Antibodies to peptides in the immediate vicinity of the substrate channel (P66-75 and P95-116) bound to their targets only after general permeabilization with Triton X-100. In contrast, the two antibodies to peptides further from the channel opening (P366-382 and P472-482) bound to their targets even in cells with intact ER membranes. These observations support our topology model in which the PGIS substrate access channel opening is positioned close to the ER membrane.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11879180      PMCID: PMC1222417          DOI: 10.1042/0264-6021:3620545

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

Review 1.  Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.

Authors:  S Moncada; J R Vane
Journal:  Pharmacol Rev       Date:  1978-09       Impact factor: 25.468

2.  Ligand partitioning into membranes: its significance in determining Km and Ks values for cytochrome P-450 and other membrane bound receptors and enzymes.

Authors:  G Parry; D N Palmer; D J Williams
Journal:  FEBS Lett       Date:  1976-08-15       Impact factor: 4.124

3.  Topographic studies of microsomal and pure prostaglandin H synthase.

Authors:  R J Kulmacz; K K Wu
Journal:  Arch Biochem Biophys       Date:  1989-02-01       Impact factor: 4.013

4.  On the membrane topology of vertebrate cytochrome P-450 proteins.

Authors:  D R Nelson; H W Strobel
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

5.  A micro-scale affinity-purification of Fab'-horseradish peroxidase conjugates and its use for sandwich enzyme immunoassay of insulin in human serum.

Authors:  K Ruan; S Hashida; S Yoshitake; E Ishikawa; O Wakisaka; Y Yamamoto; T Ichioka; K Nakajima
Journal:  Clin Chim Acta       Date:  1985-04-15       Impact factor: 3.786

6.  Purification of prostacyclin synthase from bovine aorta by immunoaffinity chromatography. Evidence that the enzyme is a hemoprotein.

Authors:  D L DeWitt; W L Smith
Journal:  J Biol Chem       Date:  1983-03-10       Impact factor: 5.157

Review 7.  Enzyme-labeling of antibodies and their fragments for enzyme immunoassay and immunohistochemical staining.

Authors:  E Ishikawa; M Imagawa; S Hashida; S Yoshitake; Y Hamaguchi; T Ueno
Journal:  J Immunoassay       Date:  1983

8.  Spectral evidence for the cytochrome P450 nature of prostacyclin synthetase.

Authors:  V Ullrich; L Castle; P Weber
Journal:  Biochem Pharmacol       Date:  1981-07-15       Impact factor: 5.858

9.  The short-neurotoxin-binding regions on the alpha-chain of human and Torpedo californica acetylcholine receptors.

Authors:  K H Ruan; B G Stiles; M Z Atassi
Journal:  Biochem J       Date:  1991-03-15       Impact factor: 3.857

10.  Characterization of the secondary structure and membrane interaction of the putative membrane anchor domains of prostaglandin I2 synthase and cytochrome P450 2C1.

Authors:  Y Lin; K K Wu; K H Ruan
Journal:  Arch Biochem Biophys       Date:  1998-04-01       Impact factor: 4.013

View more
  6 in total

1.  Inducible COX-2 dominates over COX-1 in prostacyclin biosynthesis: mechanisms of COX-2 inhibitor risk to heart disease.

Authors:  Cheng-Huai Ruan; Shui-Ping So; Ke-He Ruan
Journal:  Life Sci       Date:  2010-10-28       Impact factor: 5.037

2.  Structural and dynamic insights into substrate binding and catalysis of human lipocalin prostaglandin D synthase.

Authors:  Sing Mei Lim; Dan Chen; Hsiangling Teo; Annette Roos; Anna Elisabet Jansson; Tomas Nyman; Lionel Trésaugues; Konstantin Pervushin; Pär Nordlund
Journal:  J Lipid Res       Date:  2013-03-22       Impact factor: 5.922

3.  Manufactured nanoparticles: their uptake and effects on fish--a mechanistic analysis.

Authors:  Richard D Handy; Theodore B Henry; Tessa M Scown; Blair D Johnston; Charles R Tyler
Journal:  Ecotoxicology       Date:  2008-04-12       Impact factor: 2.823

4.  Engineering of a novel hybrid enzyme: an anti-inflammatory drug target with triple catalytic activities directly converting arachidonic acid into the inflammatory prostaglandin E2.

Authors:  Ke-He Ruan; Vanessa Cervantes; Shui-Ping So
Journal:  Protein Eng Des Sel       Date:  2009-10-22       Impact factor: 1.650

5.  Solution structure and topology of the N-terminal membrane anchor domain of a microsomal cytochrome P450: prostaglandin I2 synthase.

Authors:  Ke-He Ruan; Shui-Ping So; Weida Zheng; Jiaxin Wu; Dawei Li; Jennifer Kung
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

6.  A novel single-chain enzyme complex with chain reaction properties rapidly producing thromboxane A2 and exhibiting powerful anti-bleeding functions.

Authors:  Yan Li; Qun-Ying Li; Qing-Lan Ling; Shui-Ping So; Ke-He Ruan
Journal:  J Cell Mol Med       Date:  2019-10-19       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.